Age alone Shouldn't decide: study suggests surgery may help fit octogenarians with pancreatic cancer
NCT ID NCT07542782
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study looked at over 2,000 older adults (80+) with pancreatic cancer that hadn't spread, all in good general health. Researchers compared those who had surgery to remove the tumor with those who didn't, using data from a German cancer registry. The goal was to see if surgery could improve survival and help doctors focus on a patient's fitness rather than just their age when making treatment decisions.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If the findings are confirmed, doctors may become more willing to offer surgery to otherwise healthy older patients with pancreatic cancer, potentially improving their survival chances.
- What could go wrong
- This is a retrospective registry analysis, not a controlled trial. The results show associations, not proof that surgery causes better survival. Unmeasured factors could influence the outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
2,048 people
The number who actually took part.
- Started
-
Jan 2017
- Finished
-
Oct 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
All residents of the Federal States Brandenburg and Berlin
- Ages
-
18 to 89 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Diagnosis of invasive pancreatic carcinoma * UICC stage I-III * No distant metastases (M0) * ECOG performance status 0-1 * Diagnosis between Jan 1, 2017 and Dec 31, 2023 * Residence in Berlin or Brandenburg Exclusion Criteria: * Neuroendocrine tumors * Sarcomas
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Pancreatic cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Medical School Brandenburg
Brandenburg an der Havel, Brandenburg, 14770, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a blood test before pancreatic surgery predict a dangerous leak?
- New chemo cocktail targets pancreatic cancer at every stage
- Bacteria-Based immunotherapy targets pancreatic tumors in first human test
- Can a new radiation machine cut breath holds for cancer patients?
- Two oral drugs join chemotherapy in a bid to shrink pancreatic tumors
- Nerve-Block procedure tested against severe pancreatic and stomach cancer pain